Narasin is a novel agent that inhibits dengue virus replication in vitro through non-cytotoxic mechanisms, thus indicating its potential to be further developed as a therapeutic agent.It is used for the treatment of coccidiosis from a class of protozoa. It also triggers phospholipid scrambling of the erythrocyte cell membrane, an effect partially dependent on Ca2+ entry. It has been shown to foster apoptosis of tumor cells. References: Bouguerra G, Bissinger R, Abbès S, Lang F. Stimulation of Eryptosis by Narasin. Cell Physiol Biochem. 2015;37(5):1807-16. doi: 10.1159/000438543. Epub 2015 Nov 13. PubMed PMID: 26584281.

纯度：≥98%

CAS：55134-13-9